Book description
With a weight-of-the-evidence approach, cancer risk assessment
indentifies hazards, determines dose-response relationships, and
assesses exposure to characterize the true risk. This book focuses on
the quantitative methods for conducting chemical cancer risk assessments
for solvents, metals, mixtures, and nanoparticles. It links these to the
basic toxicology and biology of cancer, along with the impacts on
regulatory guidelines and standards. By providing insightful
perspective,
Cancer Risk Assessment
helps researchers develop a discriminate eye when it comes to
interpreting data accurately and separating relevant information from
erroneous. CHING-HUNG HSU, PhD, DABT
, is a Vice President at TaiGen Biotechnology Co., Ltd. His professional
experience includes positions at Merck & Co., Inc., the U. S.
Environmental Protection Agency, and the California Environmental
Protection Agency. Dr. Hsu earned his BS from the National Taiwan
University and PhD from the Massachusetts Institute of Technology. He
completed his postdoctoral training at the University of California at
Berkeley. Dr. Hsu is board-certified in toxicology by the American Board
of Toxicology. He has published numerous professional papers, book
chapters, and technical reports. Dr. Hsu serves on the Editorial Board
of two international peer-reviewed journals.
TODD STEDEFORD, PhD, JD, DABT, is a Toxicology Advisor and
In-house Counsel for a multinational specialty chemical manufacturer.
Previously, he was a human health toxicologist with the U. S.
Environmental Protection Agency and an adjunct scientist with the
Polish Academy of Sciences. Dr. Stedeford is board-certified in
toxicology by the American Board of Toxicology and licensed to
practice law in the District of Columbia and the State of Louisiana.
He has authored over eighty publications including peer-reviewed
scientific articles, government health assessments, legal articles,
and scientific and legal book chapters.
